8.1
CVE-2023-31167
- EPSS 0.1%
- Veröffentlicht 31.08.2023 16:15:08
- Zuletzt bearbeitet 21.11.2024 08:01:32
- Quelle security@selinc.com
- CVE-Watchlists
- Unerledigt
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal.
SEL acSELerator Bay Screen Builder software is distributed by SEL-5033 SEL acSELerator RTAC, SEL-5030 Quickset, and SEL Compass. CVE-2023-31167 and was patched in the acSELerator Bay Screen Builder release available on 20230602. Please contact SEL for additional details.
This issue affects SEL-5036 acSELerator Bay Screen Builder Software: before 1.0.49152.778.
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
Selinc ≫ Sel-5036 Acselerator Bay Screen Builder Version < 1.0.49152.778
| Typ | Quelle | Score | Percentile |
|---|---|---|---|
| EPSS | FIRST.org | 0.1% | 0.272 |
| Quelle | Base Score | Exploit Score | Impact Score | Vector String |
|---|---|---|---|---|
| nvd@nist.gov | 8.1 | 2.8 | 5.2 |
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
|
| security@selinc.com | 5 | 1.3 | 3.6 |
CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:N/I:H/A:N
|
CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.